E. Demirci Et Al. , "177Lu-DOTA-TATE therapy in patients with NETs: Toxicity, response and prognostic indicators," Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , vol.41, Gothenburg, Sweden, 2014
Demirci, E. Et Al. 2014. 177Lu-DOTA-TATE therapy in patients with NETs: Toxicity, response and prognostic indicators. Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , (Gothenburg, Sweden).
Demirci, E., Ocak, M., Kabasakal, L., Aygun, A., Araman, A., & Uslu, I., (2014). 177Lu-DOTA-TATE therapy in patients with NETs: Toxicity, response and prognostic indicators . Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Gothenburg, Sweden
Demirci, Emine Et Al. "177Lu-DOTA-TATE therapy in patients with NETs: Toxicity, response and prognostic indicators," Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Gothenburg, Sweden, 2014
Demirci, Emine M. Et Al. "177Lu-DOTA-TATE therapy in patients with NETs: Toxicity, response and prognostic indicators." Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , Gothenburg, Sweden, 2014
Demirci, E. Et Al. (2014) . "177Lu-DOTA-TATE therapy in patients with NETs: Toxicity, response and prognostic indicators." Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , Gothenburg, Sweden.
@conferencepaper{conferencepaper, author={Emine Meltem OCAK DEMİRCİ Et Al. }, title={177Lu-DOTA-TATE therapy in patients with NETs: Toxicity, response and prognostic indicators}, congress name={Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)}, city={Gothenburg}, country={Sweden}, year={2014}}